Jerry S. Lanchbury - 23 Aug 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Issuer symbol
MYGN
Transactions as of
23 Aug 2021
Net transactions value
-$660,000
Form type
4
Filing time
25 Aug 2021, 20:32:59 UTC
Previous filing
06 Aug 2021
Next filing
26 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $270,700 +10,000 +4.3% $27.07 242,550 23 Aug 2021 Direct F1
transaction MYGN Common Stock Sale $355,700 -10,000 -4.1% $35.57 232,550 23 Aug 2021 Direct F1
transaction MYGN Common Stock Options Exercise $1,082,800 +40,000 +17% $27.07 272,550 23 Aug 2021 Direct F1
transaction MYGN Common Stock Sale $1,402,800 -40,000 -15% $35.07 232,550 23 Aug 2021 Direct F1
transaction MYGN Common Stock Options Exercise $812,100 +30,000 +13% $27.07 262,550 24 Aug 2021 Direct F1
transaction MYGN Common Stock Sale $1,067,100 -30,000 -11% $35.57 232,550 24 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,000 -12% $0.000000 70,000 23 Aug 2021 Common Stock 10,000 $27.07 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -40,000 -57% $0.000000 30,000 23 Aug 2021 Common Stock 40,000 $27.07 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 24 Aug 2021 Common Stock 30,000 $27.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.